PDF herunterladen
CC BY-NC-ND 4.0 · Asian J Neurosurg
DOI: 10.1055/s-0044-1791998
Case Report

Non-Neoformans Cryptococcal Infections in the Post-Coronavirus Disease-19 (COVID-19) Era: Are We Ready to Face the Emerging Challenge?

Umayra Fatima
1   Department of Dentistry, Princess Esra Hospital, Deccan College of Medical Sciences, Hyderabad, Telangana, India
,
Hina Ahmed
2   Department of Conservative Dental Sciences, Ibn Sina National College for Medical Studies, Jeddah, Kingdom of Saudi Arabia
,
Gautam Singh
2   Department of Conservative Dental Sciences, Ibn Sina National College for Medical Studies, Jeddah, Kingdom of Saudi Arabia
,
K.Y. Giri
3   Department of Oral and Maxillofacial Surgery, Drs Sudha and Nageswara Rao Siddhartha Institute of Dental Sciences, Gannavaram, Andhra Pradesh, India
,
Md. Sania Azmi
4   Department of Oral and Maxillofacial Pathology, Care Dental College, Guntur, Andhra Pradesh, India
,
Archana Meenakshi
5   Department of Periodontology, Ragas Dental College and Hospital, Chennai, Tamil Nadu, India
,
Suresh Babu Jandrajupalli
6   Division of Periodontology, Department of Preventive Dental Sciences, College of Dentistry, University of Ha'il, Ha'il, Kingdom of Saudi Arabia
,
Swarnalatha Chandolu
6   Division of Periodontology, Department of Preventive Dental Sciences, College of Dentistry, University of Ha'il, Ha'il, Kingdom of Saudi Arabia
,
Abhishek Singh Nayyar 
7   Department of Oral Medicine and Radiology, Saraswati Dhanwantari Dental College and Hospital and Post-graduate Research Institute, Parbhani, Maharashtra, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Coronaviruses are a large group of viruses that infect animals as well as humans, while it is also suggested that, rarely, coronaviruses that infect animals can evolve and infect humans. Current evidence suggests that severe acute respiratory syndrome (SARS) coronavirus-2 leads to coronavirus disease-19 (COVID-19), the respiratory illness responsible for COVID-19 pandemic, while it has a zoonotic origin, closely related to the bat-origin SARS-like coronavirus. Also, as per the current knowledge, the disease may induce significant and persistent lymphopenia which in turn may increase the risk for various opportunistic infections. Cryptococcus laurentii is one such rare, but serious fungal infection which has been reported in post-COVID-19 disease and is a rising cause of concern since it can turn out to be fatal. The infection is caused by a non-neoformans rare human pathogen. The present case report describes the case of a 45-years old male patient who reported to the Outpatient Department (OPD) for a routine dental complaint with a grossly destructed tooth in left lower back tooth region due to extensive carious involvement, while, simultaneously, presenting with fever since 5 days in the post-COVID-19 phase, and was later diagnosed as being positive for C. laurentii infection on urine culture sensitivity test.

Keywords

coronaviruses - non-neoformans cryptococcal infections - Cryptococcus laurentii - coronavirus disease-19

Authors' Contributions

All authors contributed significantly to this work across multiple areas. They were involved in developing the concepts, designing the structure of the case report format, as well as in defining the intellectual content. Each contributed to the literature search, as well as in the acquisition and analysis of patient-related data. The manuscript was prepared with contributions from all authors, who also played key roles in editing and reviewing the final draft. Finally, all authors share responsibility as guarantors, ensuring the accuracy and integrity of the work.




Publikationsverlauf

Artikel online veröffentlicht:
04. November 2024

© 2024. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 World Health Organization (WHO). Surveillance case definitions for human infection with novel coronavirus (nCoV): Interim guidance v1,. January 2020 (Report). World Health Organization. hdl: 10665/330376. Accessed October 13, 2024 at: WHO/ 2019 -nCoV/Surveillance/v2020.1
    Suche in Google Scholar
  • 2 Centers for Disease Control and Prevention (CDC). About Novel Coronavirus ( 2019 -nCoV). United States Centers for Disease Control and Prevention. February 11, 2020. Archived from the original on February 11, 2020. Accessed February 25, 2020 at: https://www.cdc.gov/coronavirus/2019-ncov/about/index.html
    Suche in Google Scholar
  • 3 Wong G, Bi YH, Wang QH, Chen XW, Zhang ZG, Yao YG. Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important?. Zool Res 2020; 41 (03) 213-219
    CrossrefPubMedSuche in Google Scholar
  • 4 Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med 2020; 26 (04) 450-452
    CrossrefPubMedSuche in Google Scholar
  • 5 World Health Organization (WHO) Emergency Committee. Statement on the second meeting of the International Health Regulations (2005). Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). World Health Organization; January 30, 2020 . Accessed October 13, 2024 at: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
    Suche in Google Scholar
  • 6 World Health Organization (WHO) Director-General's opening remarks at the media briefing on COVID-19. World Health Organization; March 11, 2020 . Archived from the original on March 11, 2020. Accessed March 12, 2020 at: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
    Suche in Google Scholar
  • 7 Rigby J, Satija B. World Health Organization (WHO) declares end to COVID global health emergency. Reuters; May 5, 2023 . Accessed May 6, 2023 at: https://www.reuters.com/business/healthcare-pharmaceuticals/covid-is-no-longer-global-health-emergency-who-2023-05-05/
    Suche in Google Scholar
  • 8 Liu J, Li S, Liu J. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 2020; 55: 102763
    CrossrefPubMedSuche in Google Scholar
  • 9 Qin C, Zhou L, Hu Z. et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020; 71 (15) 762-768
    CrossrefPubMedSuche in Google Scholar
  • 10 Khawcharoenporn T, Apisarnthanarak A, Mundy LM. Non-neoformans cryptococcal infections: a systematic review. Infection 2007; 35 (02) 51-58
    CrossrefPubMedSuche in Google Scholar
  • 11 Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol 2019; 57 (02) 133-150
    CrossrefPubMedSuche in Google Scholar
  • 12 Cano EJ, Yetmar ZA, Razonable RR. Cryptococcus species other than Cryptococcus neoformans and Cryptococcus gattii: are they clinically significant?. Open Forum Infect Dis 2020; 7 (12) ofaa527
    CrossrefPubMedSuche in Google Scholar
  • 13 Rajasingham R, Smith RM, Park BJ. et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 2017; 17 (08) 873-881
    CrossrefPubMedSuche in Google Scholar
  • 14 Gushiken AC, Saharia KK, Baddley JW. Cryptococcosis. Infect Dis Clin North Am 2021; 35 (02) 493-514
    CrossrefPubMedSuche in Google Scholar
  • 15 Momin M, Webb G. The environmental effects on virulence factors and the antifungal susceptibility of Cryptococcus neoformans. Int J Mol Sci 2021; 22 (12) 6302
    CrossrefPubMedSuche in Google Scholar
  • 16 Khan M, Adil SF, Alkhathlan HZ. et al. COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules 2020; 26 (01) 39
    CrossrefPubMedSuche in Google Scholar
  • 17 Jin Y, Yang H, Ji W. et al. Virology, epidemiology, pathogenesis and control of COVID-19. Viruses 2020; 12 (04) 372
    CrossrefPubMedSuche in Google Scholar
  • 18 Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents?. J Microbiol Immunol Infect 2020; 53 (04) 505-512
    CrossrefPubMedSuche in Google Scholar
  • 19 Pemán J, Ruiz-Gaitán A, García-Vidal C. et al. Fungal co-infection in COVID-19 patients: should we be concerned?. Rev Iberoam Micol 2020; 37 (02) 41-46
    CrossrefPubMedSuche in Google Scholar
  • 20 Pasero D, Sanna S, Liperi C. et al. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection 2021; 49 (05) 1055-1060
    CrossrefPubMedSuche in Google Scholar
  • 21 Salehi M, Ahmadikia K, Badali H, Khodavaisy S. Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran. Mycopathologia 2020; 185 (04) 607-611
    CrossrefPubMedSuche in Google Scholar
  • 22 Binder L, Csillag A, Toth G. Diffuse infiltration of the lungs associated with Cryptocococcus luteolus. Lancet 1956; 270 (6931) 1043-1045
    CrossrefPubMedSuche in Google Scholar
  • 23 Krumholz RA. Pulmonary cryptococcosis. A case due to Cryptococcus albidus. Am Rev Respir Dis 1972; 105 (03) 421-424
    PubMedSuche in Google Scholar
  • 24 Melo JC, Srinivasan S, Scott ML, Raff MJ. Cryptococcus albidus meningitis. J Infect 1980; 2 (01) 79-82
    CrossrefPubMedSuche in Google Scholar
  • 25 Khatib MY, Ahmed AA, Shaat SB, Mohamed AS, Nashwan AJ. Cryptococcemia in a patient with COVID-19: a case report. Clin Case Rep 2020; 9 (02) 853-855
    CrossrefPubMedSuche in Google Scholar
  • 26 Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med 2020; 30 (02) 100971
    CrossrefPubMedSuche in Google Scholar
  • 27 Johnson LB, Bradley SF, Kauffman CA. Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses 1998; 41 (7-8): 277-280
    CrossrefPubMedSuche in Google Scholar
  • 28 Kordossis T, Avlami A, Velegraki A. et al. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Med Mycol 1998; 36 (05) 335-339
    CrossrefPubMedSuche in Google Scholar
  • 29 Shankar EM, Kumarasamy N, Bella D. et al. Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS. Can Respir J 2006; 13 (05) 275-278
    CrossrefPubMedSuche in Google Scholar
  • 30 Cheng MF, Chiou CC, Liu YC, Wang HZ, Hsieh KS. Cryptococcus laurentii fungemia in a premature neonate. J Clin Microbiol 2001; 39 (04) 1608-1611
    CrossrefPubMedSuche in Google Scholar
  • 31 Sinnott IV JT, Rodnite J, Emmanuel PJ, Campos A. Cryptococcus laurentii infection complicating peritoneal dialysis. Pediatr Infect Dis J 1989; 8 (11) 803-805
    CrossrefPubMedSuche in Google Scholar
  • 32 Lynch III JP, Schaberg DR, Kissner DG, Kauffman CA. Cryptococcus laurentii lung abscess. Am Rev Respir Dis 1981; 123 (01) 135-138
    PubMedSuche in Google Scholar
  • 33 Kamalam A, Yesudian P, Thambiah AS. Cutaneous infection by Cryptococcus laurentii. Br J Dermatol 1977; 97 (02) 221-223
    CrossrefPubMedSuche in Google Scholar
  • 34 Song KD, Lee KS, Chung MP. et al. Pulmonary cryptococcosis: imaging findings in 23 non-AIDS patients. Korean J Radiol 2010; 11 (04) 407-416
    CrossrefPubMedSuche in Google Scholar
  • 35 Gupta M, Mishra AK, Singh SK. Cryptococcus laurentii fungemia in a low birth weight preterm neonate: India. J Infect Public Health 2018; 11 (06) 896-897
    CrossrefPubMedSuche in Google Scholar
  • 36 Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia 2020; 185 (04) 599-606
    CrossrefPubMedSuche in Google Scholar
  • 37 Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol 2021; 69 (02) 244-252
    CrossrefPubMedSuche in Google Scholar
  • 38 Kanwar A, Jordan A, Olewiler S, Wehberg K, Cortes M, Jackson BR. A fatal case of Rhizopus azygosporus pneumonia following COVID-19. J Fungi (Basel) 2021; 7 (03) 174
    CrossrefPubMedSuche in Google Scholar
  • 39 Moorthy A, Gaikwad R, Krishna S. et al. SARS-CoV-2, uncontrolled diabetes and corticosteroids- an unholy trinity in invasive fungal infections of the maxillofacial region?: a retrospective, multi-centric analysis. J Maxillofac Oral Surg 2021; 20 (03) 418-425
    CrossrefPubMedSuche in Google Scholar
  • 40 Karimi-Galougahi M, Arastou S, Haseli S. Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol 2021; 11 (06) 1029-1030
    CrossrefPubMedSuche in Google Scholar
  • 41 Waizel-Haiat S, Guerrero-Paz JA, Sanchez-Hurtado L, Calleja-Alarcon S, Romero-Gutierrez L. A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19. Cureus 2021; 13 (02) e13163
    CrossrefPubMedSuche in Google Scholar
  • 42 Gangneux JP, Dannaoui E, Fekkar A. et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med 2022; 10 (02) 180-190
    CrossrefPubMedSuche in Google Scholar